Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBlue Shield CA Polysomnography Coverage | OpenPaye…
    Ask Trek AI about this page
    ModifiedBlue Shield of CaliforniaPolicy 2.01.99

    Polysomnography for Non-Respiratory Sleep Disorders

    Customize your policy alerts

    Sign up for blue_shield_of_california Policy 2.01.99 alerts

    Get alerted when Policy 2.01.99 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs when polysomnography, including PSG followed by next-day MSLT, may be medically necessary for suspected narcolepsy, idiopathic hypersomnia, parasomnias, and periodic limb movement disorder, and identifies investigational sleep-disorder evaluations.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerBlue Shield of California
    PolicyPolysomnography for Non-Respiratory Sleep Disorders
    Policy CodePolicy 2.01.99
    Change TypeModified
    Effective DateSep 1, 2026
    Next Review DateN/A
    Key ActionSubmit history and physical or consultation notes documenting the reason for PSG, sleep-disorder symptoms, and prior treatments with their duration and response.
    SourceLink
    POLICY UPDATE CHANGES

    The policy statement was revised to specify suspected narcolepsy and idiopathic hypersomnia as indications for PSG followed by next-day MSLT.

    The parasomnia criteria were revised to focus on a history of sleep-related injurious or potentially injurious disruptive behaviors.

    The periodic limb movement disorder criteria and related investigational exclusions were revised.

    The coding section was updated to include the listed PSG and MSLT procedure codes.

    2Qualifying conditions for PSG followed by next-day MSLT
    1Qualifying parasomnia feature
    4Non-respiratory sleep-disorder evaluations listed as investigational
    4Concurrent conditions making PLMD PSG investigational
    5Listed PSG and MSLT procedure codes

    Medical Necessity Criteria

    PSG followed by next-day MSLT

    May be medically necessary when ANY of the following suspected conditions is present.

    Suspected qualifying condition

    • Narcolepsy: Suspected narcolepsy.
    • Idiopathic hypersomnia: Suspected idiopathic hypersomnia.

    PSG for parasomnias

    PSG may be medically necessary when ALL of the following are met.

    Qualifying parasomnia: The individual has a history of sleep-related injurious or potentially injurious disruptive behaviors.

    PSG for periodic limb movement disorder

    PSG may be medically necessary when ALL of the following are met.

    Periodic limb movement disorder evaluation

    • Repetitive limb movement: The individual or an observer reports repetitive limb movement during sleep.
    • At least one associated symptom

      • Frequent awakenings.
      • Fragmented sleep.
      • Difficulty maintaining sleep.
      • Excessive daytime sleepiness.

    Investigational PSG indications

    Considered investigational when the policy criteria are not met.

    Nonqualifying non-respiratory sleep-disorder evaluation

    • Nightmare disorder.
    • Depression.
    • Sleep-related bruxism.
    • Non-injurious disorders of arousal.

    Investigational PLMD PSG contexts

    Considered investigational when ANY of the following is present.

    Excluded concurrent condition or context

    • Concurrent untreated obstructive sleep apnea.
    • Restless legs syndrome.
    • Narcolepsy.
    • Rapid eye movement sleep behavior disorder.

    Suspected periodic limb movement disorder

    PSG is indicated when ALL of the following are present.

    Suspected periodic limb movement disorder: A diagnosis of periodic limb movement disorder is being considered because the patient or an observer reports repetitive limb movement during sleep and associated sleep or daytime symptoms.

    Associated symptoms include frequent awakenings, fragmented sleep, difficulty maintaining sleep, or excessive daytime sleepiness.

    Atypical or potentially injurious parasomnias

    PSG may be indicated or is indicated in selected parasomnia and seizure-related evaluations.

    Selected unusual or high-risk sleep behaviors: PSG is indicated for sleep behaviors suggestive of parasomnias that are unusual or atypical because of the age at onset, timing, duration, frequency, or specific motor patterns, or for violent or potentially injurious sleep-related behaviors.

    PSG may also be considered when forensic considerations exist or when a presumed parasomnia or sleep-related seizure disorder does not respond to conventional therapy.

    Situations generally not requiring routine PSG

    PSG is generally not routinely indicated in ANY of the following circumstances.

    • Typical uncomplicated noninjurious parasomnia: Typical, uncomplicated, noninjurious parasomnias that can usually be diagnosed clinically.
    • Seizure disorder without sleep-disorder complaints: A seizure disorder without specific complaints consistent with a sleep disorder.
    • Restless legs syndrome without diagnostic uncertainty: Restless legs syndrome, except when uncertainty exists in the diagnosis.
    • Circadian rhythm sleep disorders.

    PSG followed by next-day MSLT

    PSG and a next-day MSLT may be considered medically necessary when evaluating one of the following suspected conditions.

    Qualifying suspected condition

    • Suspected narcolepsy: Evaluation of suspected narcolepsy.
    • Suspected idiopathic hypersomnia: Evaluation of suspected idiopathic hypersomnia.

    Parasomnia evaluation

    PSG may be medically necessary when evaluating individuals with parasomnias with the following feature.

    Injurious or potentially injurious parasomnia behavior: A history of sleep-related injurious or potentially injurious disruptive behaviors.

    Periodic limb movement disorder

    PSG may be medically necessary for consideration of periodic limb movement disorder when ALL of the following are met.

    Periodic limb movement disorder evaluation

    • Observed or reported limb movements: A complaint of repetitive limb movement during sleep by the individual or an observer.
    • No concurrent sleep disorder: No other concurrent sleep disorder.
    • Qualifying symptom

      • Frequent awakenings.
      • Fragmented sleep.

    Typical and benign parasomnias, including sleepwalking and sleep terrors, can generally be diagnosed from clinical features alone. These conditions are not qualifying indications for polysomnography (PSG) under the policy.

    PSG for the diagnosis of periodic limb movement disorder (PLMD) is considered investigational when any of the following is present: concurrent untreated obstructive sleep apnea, restless legs syndrome, narcolepsy, or rapid eye movement sleep behavior disorder.

    PSG is not routinely indicated to diagnose or treat restless legs syndrome, except when there is diagnostic uncertainty. PSG is also not routinely indicated for the diagnosis of circadian rhythm sleep disorders.

    PSG is not routinely indicated for typical, uncomplicated, noninjurious parasomnias. It is also not routinely indicated for patients with a seizure disorder who have no specific complaints consistent with a sleep disorder.

    The current criteria consider PLMD PSG medically necessary only when the evaluation includes reported or observed repetitive limb movement during sleep, no other concurrent sleep disorder, and at least one associated symptom: frequent awakenings, fragmented sleep, difficulty maintaining sleep, or excessive daytime sleepiness. PSG is investigational when untreated obstructive sleep apnea, restless legs syndrome, narcolepsy, or rapid eye movement sleep behavior disorder is also present.

    PSG is considered investigational for non-respiratory sleep disorders that do not meet the policy criteria. Listed examples include nightmare disorder, depression, sleep-related bruxism, and noninjurious disorders of arousal.

    Applicable Codes

    FDA Product Codemixed
    OLVU.S. Food and Drug Administration product code for PSG devices
    CPTCPT
    95782Polysomnography; younger than 6 years, sleep staging with 4 or more additional parameters of sleep, attended by a technologist.
    95805Multiple sleep latency or maintenance of wakefulness testing, recording, analysis and interpretation of physiological measurements of sleep during multiple trials to assess sleepiness.
    95808Polysomnography; any age, sleep staging with 1-3 additional parameters of sleep, attended by a technologist.
    95810Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist.
    HCPCSHCPCS
    95811Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist.

    Documentation and Review Considerations

    Documentation Required

    Document PLMD symptoms and sleep behaviors

    For suspected periodic limb movement disorder, document repetitive limb movement during sleep and associated symptoms. Include frequent awakenings, fragmented sleep, difficulty maintaining sleep, or excessive daytime sleepiness, as applicable.

    • Document the movement reported by the individual or an observer.
    • Record at least one associated sleep or daytime symptom.
    Documentation Required

    Submit clinical review documentation

    Submit history and physical and/or consultation notes documenting the reason for polysomnography, symptoms of the sleep disorder, and prior treatment(s), including duration and response(s).

    • Reason for polysomnography
    • Symptoms of the sleep disorder
    • Prior treatment(s), including duration and response(s)

    Clinical and Technical Background

    Polysomnography (PSG) records multiple physiologic parameters relevant to sleep, such as brain activity, muscle activity, eye movements, respiratory measures, oxygen saturation, cardiac activity, and limb movements. Video recording may also be used to assess parasomnias, including rapid eye movement sleep behavior disorder, by documenting sleep-related behaviors and relevant motor activity.

    Terms and Clinical Concepts

    Narcolepsy
    NatureNeurologic disorder characterized predominantly by abnormalities of rapid eye movement (REM) sleep and some abnormalities of non-REM (NREM) sleep.
    Core symptomExcessive daytime sleepiness that cannot be fully relieved by any amount of sleep.
    Classic symptomsHypersomnolence, cataplexy, sleep paralysis, and hypnagogic hallucinations.
    Multiple sleep latency test (MSLT)
    SettingThe patient lies down in a dark, quiet room.
    AssessmentAssesses the time to enter the different stages of sleep.
    Schedule
    Policy Summary
    PayerBlue Shield of California
    PolicyPolysomnography for Non-Respiratory Sleep Disorders
    Policy CodePolicy 2.01.99
    Change TypeModified
    Effective DateSep 1, 2026
    Next Review DateN/A
    Key ActionSubmit history and physical or consultation notes documenting the reason for PSG, sleep-disorder symptoms, and prior treatments with their duration and response.
    SourceLink
    On This Page
    Medical Necessity CriteriaApplicable CodesDocumentation and Review ConsiderationsClinical and Technical BackgroundTerms and Clinical Concepts
    Difficulty maintaining sleep.
  1. Excessive daytime sleepiness.
  2. Billing Rule

    Submit post-service test reports

    After the service, submit the polysomnography report and, if applicable, the multiple sleep latency test report.

    • Polysomnography report
    • Multiple sleep latency test report, if applicable
    Denial Risk

    Avoid PSG for nonqualifying indications

    PSG is considered investigational for diagnosis of non-respiratory sleep disorders that do not meet the policy criteria. Examples include nightmare disorder, depression, sleep-related bruxism, and non-injurious disorders of arousal.

    • Nightmare disorder
    • Depression
    • Sleep-related bruxism
    • Non-injurious disorders of arousal
    Denial Risk

    Screen for excluded concurrent conditions

    PSG for the diagnosis of periodic limb movement disorder is considered investigational when there is a concurrent excluded condition, including untreated obstructive sleep apnea, restless legs syndrome, narcolepsy, or rapid eye movement sleep behavior disorder.

    • Concurrent untreated obstructive sleep apnea
    • Restless legs syndrome
    • Narcolepsy
    • Rapid eye movement sleep behavior disorder
    Denial Risk

    Exclude concurrent sleep disorders in PLMD evaluation

    Before requesting PSG for periodic limb movement disorder, confirm that no other concurrent sleep disorder is present. PSG is considered investigational when concurrent untreated obstructive sleep apnea, restless legs syndrome, narcolepsy, or rapid eye movement sleep behavior disorder is present.

    • Confirm no other concurrent sleep disorder.
    • Do not use PSG for PLMD diagnosis in the presence of the listed concurrent conditions.
    Denial Risk

    Verify the non-respiratory indication qualifies

    PSG is considered investigational for non-respiratory sleep disorders that do not meet the policy criteria, including nightmare disorder, depression, sleep-related bruxism, and noninjurious disorders of arousal.

    • Confirm that the indication meets the stated medical-necessity criteria.
    • Do not submit PSG for the listed non-qualifying disorders as a covered qualifying indication.
    Testing is repeated every 2 hours throughout the day.
    Typical sleep-onset limitThe maximum time allowed to fall asleep is typically 20 minutes.
    Parasomnias
    DefinitionAbnormal behavioral, experiential, or physiologic events.
    TimingEvents may occur during entry into sleep, within sleep, or during arousals from sleep.
    Potential impactSome parasomnias can cause serious disruption of sleep-wake schedules and injury to the patient or others.
    Narcolepsy
    Excessive sleepinessExcessive daytime sleepiness cannot be fully relieved by any amount of sleep.
    REM sleepNarcolepsy is characterized predominantly by abnormalities of REM sleep.
    NREM sleepSome abnormalities of NREM sleep may also occur.
    Typical MSLT findingsPatients often have a mean sleep latency of fewer than 5 minutes and 2 or more early-onset REM periods during MSLT naps.
    Multiple Sleep Latency Test (MSLT)
    Test typeA daytime sleep test performed with the patient lying down in a dark, quiet room.
    Sleep-onset measureMeasures the time to sleep onset.
    Sleep-stage assessmentIdentifies entry into different sleep stages and sleep-stage transitions.
    Nap intervalNaps are typically repeated every 2 hours.
    Narcolepsy type 2
    Chronic sleepinessInvolves chronic sleepiness.
    MSLTA positive MSLT is present.
    CataplexyOccurs without cataplexy.
    Hypocretin-1Hypocretin-1 levels are in the normal range in most patients.
    REM sleep behavior disorder (RBD)
    ClassificationREM sleep behavior disorder is a parasomnia.
    Muscle toneMuscle tone is maintained during REM sleep rather than the usual near-complete atonia.
    BehaviorsDream-enactment behaviors may include talking, shouting, gesturing, grabbing, punching, kicking, or leaping from bed.
    RiskViolent episodes may place the patient or bed partner at risk of harm.
    Disorders of arousal
    ClassificationDisorders of arousal are NREM parasomnias.
    MechanismThey result from intrusion of wakefulness into NREM sleep.
    ExamplesExamples include confusional arousals, sleepwalking, and sleep terrors.
    Typical awarenessThe patient may appear awake but is often unresponsive to external stimuli and amnestic to the event.
    Restless legs syndrome (RLS)
    ClassificationRestless legs syndrome is a neurologic disorder.
    SensationsIt causes uncomfortable or odd sensations in the legs, often described as creeping, crawling, itchy, burning, or tingling.
    Urge to moveThere is an urge to move the legs to relieve the sensations.
    TimingSymptoms usually occur during relaxation and primarily in the evening.
    Periodic limb movement disorder (PLMD)
    Movement typeInvoluntary, stereotypic, repetitive limb movements occur during sleep.
    Common locationsMovements most often involve the lower extremities, including the toes, ankles, knees, and hips; the upper extremities may also be involved.
    Sleep effectsMovements can fragment sleep architecture, cause frequent awakenings, reduce slow-wave sleep, and decrease sleep efficiency.
    Associated conditionsPeriodic limb movements are commonly associated with RLS, RBD, or narcolepsy.
    Polysomnography (PSG)
    DefinitionA recording of multiple physiologic parameters relevant to sleep.
    Brain and muscle measuresIncludes electroencephalography, chin electromyography, and electrooculography.
    Respiratory and cardiac measuresIncludes respiratory effort, airflow, oxygen saturation, and electrocardiography.
    Movement and behaviorIncludes anterior tibialis electromyography to assess periodic limb movements and potentially video recording to detect unusual behavior.
    Clinically valid
    Condition detectionDetects the presence or absence of a condition.
    Future riskDetects the risk of developing a condition in the future.
    Treatment responseDetects treatment response, whether beneficial or adverse.
    Clinically useful
    Management relevanceTest results inform management decisions.
    Net health outcomeThose decisions improve the net health outcome of care.
    Effective treatmentThe test may enable correct or more effective therapy.
    AvoidanceThe test may help avoid unnecessary therapy or testing.
    Direct evidence
    Evidence sourceStudies compare health outcomes for patients managed with and without the test.
    Evidence typeDirect evidence addresses the clinical utility of the test.
    Preferred designRandomized controlled trials are the preferred intervention design.
    Chain of evidence
    Evidence typeChain of evidence is indirect evidence of clinical utility.
    FoundationIt rests on evidence of clinical validity.
    LimitationIf test performance is not adequately demonstrated, clinical utility cannot be inferred.
    Clinically useful
    Management relevanceTest results inform management decisions.
    Net health outcomeThe decisions improve the net health outcome of care.
    Potential benefitResults may enable correct or more effective therapy or avoid unnecessary therapy or testing.
    Direct evidence
    ComparisonStudies compare health outcomes in patients managed with and without the test.
    Clinical utilityThe comparison provides direct evidence of clinical utility.
    Preferred designRandomized controlled trials are preferred.
    Chain of evidence
    Evidence typeChain of evidence is indirect evidence of clinical utility.
    BasisIt rests on evidence of clinical validity.
    Inference limitWithout sufficient evidence that the test performs adequately, no inference about clinical utility can be made.
    Clinically valid
    Condition detectionDetects the presence or absence of a condition.
    Future riskDetects future risk of a condition.
    Treatment responseDetects treatment response.
    REM sleep without atonia
    Submental activityDefined by sustained or intermittent elevation of submental electromyogram tone.
    Limb activityAlso defined by excessive phasic muscle activity in the limb electromyogram.
    Clinical relevanceREM sleep without atonia is a minimal diagnostic criterion for REM sleep behavior disorder.
    Clinically valid
    Condition detectionDetects the presence or absence of a condition.
    Future riskDetects the risk of developing a condition in the future.
    Treatment responseDetects beneficial or adverse treatment response.
    Clinically useful
    Management relevanceResults inform management decisions.
    Net health outcomeThe decisions improve the net health outcome of care.
    Treatment or testingResults may enable correct or more effective therapy or avoid unnecessary therapy or testing.
    Restless legs syndrome
    Urge to moveAn urge to move the limbs, usually associated with paresthesias or dysesthesias.
    Rest-related worseningSymptoms start or worsen with rest.
    Activity reliefPhysical activity provides at least partial relief.
    Evening patternSymptoms worsen in the evening or at night.
    Polysomnography (PSG)
    DefinitionA sleep study that records multiple physiologic parameters relevant to sleep.
    VideoVideo recording may also be performed.
    Use of videoVideo may be used to evaluate parasomnias.
    Clinically valid
    Condition detectionDetects the presence or absence of a condition.
    Future riskDetects the risk of developing a condition in the future.
    Treatment responseDetects beneficial or adverse treatment response.
    Clinically useful
    Management relevanceResults inform management decisions.
    Net health outcomeThe decisions improve the net health outcome of care.
    Potential benefitResults may provide correct or more effective therapy or avoid unnecessary therapy or testing.
    Chain of evidence
    Evidence typeChain of evidence is indirect evidence of clinical utility.
    BasisIt is based on clinical validity.
    Inference limitIf test performance is insufficiently established, clinical-utility inferences cannot be made.
    MSLT
    ExpansionMSLT means multiple sleep latency test.
    TimingIt is a daytime test preceded by nocturnal polysomnography.
    PurposeIt assesses excessive sleepiness and assists in differentiating hypersomnia from narcolepsy.
    PLMD
    AbbreviationPLMD.
    Full termPeriodic limb movement disorder.
    Clinical contextThe term describes a sleep disorder involving periodic limb movements.
    NREM
    AbbreviationNREM.
    Full termNon-rapid eye movement.
    Clinical contextNREM refers to non-rapid eye movement sleep.